Gennex Laboratories Intrinsic Value

Gennex Laboratories intrinsic value. Gennex Laboratories (GENNEX) median intrinsic value is ₹17.74 from 9 valuation models (range ₹4–₹27), vs current price ₹8.87 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse GENNEX institutional holdings to track promoter, FII and institutional holdings.

Market Price (CMP)
₹8.87
Primary Intrinsic Value
₹14.96
Market Cap
₹21.3 Cr
+100.0% Upside
Median Value
₹17.74
Value Range
₹4 - ₹27
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

GENNEX Valuation Methods Summary — DCF, Graham Number & P/E

Gennex Laboratories intrinsic value across 9 models vs current price ₹8.87 — upside/downside and value range per method. For current market price and key ratios, visit Gennex Laboratories share price chart.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹14.96 ₹11.97 - ₹17.95 +68.7% EPS: ₹0.68, Sector P/E: 22x
Book Value Method asset ₹22.17 ₹19.95 - ₹24.39 +149.9% Book Value/Share: ₹97.08, P/B: 2.0x
Revenue Multiple Method revenue ₹17.74 ₹15.97 - ₹19.51 +100.0% Revenue/Share: ₹73.33, P/S: 2.0x
EBITDA Multiple Method earnings ₹17.74 ₹15.97 - ₹19.51 +100.0% EBITDA: ₹28.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹22.17 ₹17.74 - ₹26.60 +149.9% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹4.35 ₹3.91 - ₹4.79 -51.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹10.51 ₹9.46 - ₹11.56 +18.5% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹17.74 ₹15.97 - ₹19.51 +100.0% ROE: 8.6%, P/E Multiple: 10x
Graham Defensive Method conservative ₹26.61 ₹23.95 - ₹29.27 +200.0% EPS: ₹0.68, BVPS: ₹97.08
Method Types: Earnings Asset DCF Growth Dividend Conservative

GENNEX Intrinsic Value vs Market Price — All Valuation Models

Gennex Laboratories fair value range ₹4–₹27 vs current market price ₹8.87 across 9 valuation models. Browse GENNEX income statement for revenue, profit, balance sheet and cash flow data.

GENNEX Intrinsic Value Analysis — Undervalued or Overvalued?

Gennex Laboratories median intrinsic value ₹17.74, current price ₹8.87 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of GENNEX?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gennex Laboratories (GENNEX) is ₹17.74 (median value). With the current market price of ₹8.87, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹4.35 to ₹26.61, indicating ₹4.35 - ₹26.61.

Is GENNEX undervalued or overvalued?

Based on our multi-method analysis, Gennex Laboratories (GENNEX) appears to be trading below calculated value by approximately 100.0%.

GENNEX Financial Health — Key Ratios vs Industry Benchmarks

Gennex Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 8.6% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 13.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.50x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

GENNEX Cash Flow Quality — Operating & Free Cash Flow

Gennex Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-64 Cr ₹-67 Cr Negative Cash Flow 3/10
March 2025 ₹-10 Cr ₹-10 Cr Negative Cash Flow 3/10
March 2024 ₹-47 Cr ₹-47 Cr Negative Cash Flow 3/10
March 2023 ₹24 Cr ₹5 Cr Positive Free Cash Flow 7/10
March 2022 ₹12 Cr ₹11 Cr Positive Free Cash Flow 8/10